What question did this study set out to answer?

Examine the changing role of beta-blockers in ischemic heart failure following modern myocardial infarction treatments.

March 23, 2026Heart Failure ReviewsOpen Access

The prognostic impact of beta blockers in ischemic heart failure: time for a paradigm shift?

View Full Paper

Ask AI

Bookmark

Authors

Review evaluates beta-blockers' effectiveness in heart failure post-myocardial infarction, suggesting updated clinical strategies.

Examine the changing role of beta-blockers in ischemic heart failure following modern myocardial infarction treatments.
Reviewed historical and recent studies on beta-blockers in ischemic heart failure.
Identified factors influencing beta-blocker therapy including left ventricular ejection fraction and comorbidities.
Designed an algorithm for personalized beta-blocker therapy decisions.
Beta-blocker efficacy in ischemic heart failure may differ in the post-reperfusion era.
Reassessment indicates variability in patient responses based on ejection fraction and clinical profiles.
The proposed algorithm aims to tailor beta-blocker use for improved patient outcomes.

Castiello et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark